Regan Barry Saveall
Chief Executive Officer bei DRAGONFLY BIOSCIENCES LIMITED
Profil
Regan Barry Saveall is currently the Chief Executive Officer at Dragonfly Biosciences Ltd.
(Australia) since 2019 and also currently the Director at NBC Universal Global Networks Management Ltd.
since 2016.
He was formerly the Chief Financial Officer at Dragonfly Biosciences Ltd.
(United Kingdom) in 2019.
Aktive Positionen von Regan Barry Saveall
| Unternehmen | Position | Beginn |
|---|---|---|
| DRAGONFLY BIOSCIENCES LIMITED | Chief Executive Officer | 01.11.2019 |
NBC Universal Global Networks Management Ltd.
 NBC Universal Global Networks Management Ltd. Financial ConglomeratesFinance Founded in 1998, NBC Universal Global Networks Management Ltd. is a British company that provides investment services. Part of Comcast Corp., the private company is based in London, UK. | Director/Board Member | 24.02.2016 |
Ehemalige bekannte Positionen von Regan Barry Saveall
| Unternehmen | Position | Ende |
|---|---|---|
Dragonfly Biosciences Ltd. (United Kingdom)
 Dragonfly Biosciences Ltd. (United Kingdom) Pharmaceuticals: OtherHealth Technology Dragonfly Biosciences Ltd. manufactures and supplies natural cannabidiol based health supplements and skin care products. The firm offers the products under its own brand Dragonfly CBD. The company was founded by Mark Grenside, Chris Wronski and Radost Draganova on June 29, 2017 and is headquartered in London, the United Kingdom. | Chief Executive Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
NBC Universal Global Networks Management Ltd.
NBC Universal Global Networks Management Ltd. Financial ConglomeratesFinance Founded in 1998, NBC Universal Global Networks Management Ltd. is a British company that provides investment services. Part of Comcast Corp., the private company is based in London, UK. | Finance |
Dragonfly Biosciences Ltd. (United Kingdom)
Dragonfly Biosciences Ltd. (United Kingdom) Pharmaceuticals: OtherHealth Technology Dragonfly Biosciences Ltd. manufactures and supplies natural cannabidiol based health supplements and skin care products. The firm offers the products under its own brand Dragonfly CBD. The company was founded by Mark Grenside, Chris Wronski and Radost Draganova on June 29, 2017 and is headquartered in London, the United Kingdom. | Health Technology |
Dragonfly Biosciences Ltd. (Australia)
 Dragonfly Biosciences Ltd. (Australia) Pharmaceuticals: OtherHealth Technology Dragonfly Biosciences Ltd. develops cannabidiol (CBD) health and wellness products. It engages in the production, research and sales of CBD and other hemp-based extracts & CBD products through its subsidiary Dragonfly UK. The company was founded in May 2009 and is headquartered in Sydney, Australia. | Health Technology |
